SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
-15.6%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 138.92% |
| 2024 | 19.17% |
| 2023 | -125.14% |
| 2022 | -9.31% |
| 2021 | -185.22% |
| 2020 | 323.88% |
| 2019 | 0.00% |